May 20 @ 1:00 pm – 2:00 pm PDT
Innovation Theater 5
Supported By: Axsome Therapeutics, Inc.
Program Description
- Overview of mechanism, prevalence, and disease burden of Excessive Daytime Sleepiness due to Obstructive Sleep Apnea
- Efficacy and Safety Data for a prescription medicine for the treatment of Excessive Daytime Sleepiness due to Obstructive Sleep Apnea
Speakers
Presenter: Bruce C. Corser, MD, MBA, FAASM
CEO & Medical Director, Sleep Management Institute
CEO, Your MD
CEO & President, Intrepid Research, LLC
Cincinnati, Ohio
Presenter: Edward Mezerhane, MD, FAASM, FACP
Medical Director, Sleep Medicine Specialists of South Florida
Principal Investigator, PharmaDev Clinical Research Institute,
Miami, Florida